ACHR-WS (ACHR-WS)

Achieve Life Sciences, Inc. (Ticker: ACHR-WS) is a clinical-stage biopharmaceutical company focused on transforming the landscape of smoking cessation and nicotine addiction treatment through its lead candidate, cytisine. The firm aims to address a significant public health issue by enhancing nicotine replacement strategies to improve efficacy and patient outcomes. With a robust product pipeline and strategic partnerships, Achieve is well-positioned to capitalize on the growing demand for innovative cessation alternatives. Committed to scientific rigor and patient-centric approaches, Achieve is positioned to become a key player in the fight against nicotine dependence and drive meaningful change in tobacco control.